A new dengue vaccine (TAK-003) now WHO recommended in endemic areas; what about travellers?
David O. Freedman
Abstract
Qdenga (Takeda) is now WHO recommended for residents of highly endemic areas. Travellers from dengue non-endemic countries with previous travel-related dengue (any serotype) will benefit from TAK-003 vaccination to prevent a secondary dengue infection during future dengue risk travel. Dengue-naïve travellers have less potential benefit and use will remain discretionary for now.
Topics & Concepts
Dengue feverDengue vaccineMedicineVaccinationDengue virusTravel medicineSerotypeEnvironmental healthEndemic diseasesVirologyPsychiatryMosquito-borne diseases and controlTravel-related health issuesMalaria Research and Control